Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PuraPharm Corp. Ltd. ( (HK:1498) ) has provided an update.
PuraPharm Corporation Limited has issued a profit warning, indicating an expected net loss of approximately HK$24 million for the first half of 2025, compared to a HK$18.7 million loss in the same period of 2024. The anticipated loss is attributed to decreased revenue due to slowed consumption and increased competition in Hong Kong, alongside higher costs of goods sold driven by rising raw material prices and environmental challenges. The interim results are still being finalized and may differ from the preliminary figures.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, primarily operating in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products, with a focus on the Hong Kong market.
Average Trading Volume: 142,004
Technical Sentiment Signal: Sell
Current Market Cap: HK$175.7M
For detailed information about 1498 stock, go to TipRanks’ Stock Analysis page.